Pharmafile Logo
Pharmafocus logo
Advanced Search

Paul Barrow joins CiToxLAB

July 14, 2011
Research and Development appointment, research and development

French CRO CiToxLAB has appointed Paul Barrow as director of scientific projects and client consulting. He joins the Evreux-based company, …

Appointment
Newcastle GP consortia

What now for GP consortia?

July 13, 2011
Sales and Marketing GP consortia, NHS reforms

David Cameron unveiled major changes to the direction of the health reforms on 8 June – and in doing so, …

Feature

Sanofi eyes phase III move for sarilumab in rheumatoid arthritis

July 13, 2011
Research and Development Regeneron, Sanofi, ankylosing spondylitis, research and development news, rheumatoid arthritis, sarilumab

Sanofi is poised to move sarilumab into phase III trials for rheumatoid arthritis after the monoclonal antibody showed positive results …

News
US Food and Drug Administration

Pharma regulators consult on drug development initiatives

July 13, 2011
Research and Development Companion Diagnostics, EMA, FDA, Pharmacogenomics, biomarkers, research and development news

Pharma regulators in the US and Europe have put out separate consultations on issues affecting how medicines are developed. The …

News
Amgen

Amgen collaborates on cancer antibody research

July 13, 2011
Research and Development Amgen, Cancer, TGF-beta monoclonal antibody, research and development news

Amgen has teamed up with German biotech Micromet to develop tumour-destroying antibodies in a two-year deal that could net Micromet …

News
clavis_pharma_nicholas_adams

Clavis Pharma appoints Nicholas Adams

July 13, 2011
Research and Development appointment, research and development

Norwegian cancer drug development company Clavis Pharma has appointed Nicholas Adams as chief business officer. He has more than 23 …

Appointment

Kantar Health Launches Global Health and Wellness Quarterly Update

July 12, 2011
Sales and Marketing Kantar Health, depression, emerging markets, information, newsletter, work productivity

The inaugural issue of Kantar Health’s Global Health and Wellness Update is now available. This is a quarterly newsletter sharing …

News
Press release
Sanofi's Multaq (dronedarone)

EMA widens safety review of Sanofi’s Multaq

July 12, 2011
Sales and Marketing Multaq, Sanofi

European regulators are to extend their assessment of the risks associated with Sanofi’s atrial fibrillation (AF) medicine Multaq to take …

News

Cellectis appoints Dr Andrew Scharenberg

July 12, 2011
Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

Paris-based genome engineering specialist Cellectis Therapeutics has appointed Dr Andrew Scharenberg as chief scientific officer. He is an attending physician …

Appointment

EMA plans adverse event reports for the public

July 12, 2011
Research and Development, Sales and Marketing EMA, adverse events, patient information

The EMA will start producing monthly adverse event reports for the public as part of its plans to open up …

News

New $50m plant unveiled by Kyowa Hakko Kirin

July 12, 2011
Manufacturing and Production Kyowa Hakko Kirin, pharma manufacturing news

Japan’s Kyowa Hakko Kirin is to build a new manufacturing unit for oral formulations at its main production facility in …

News

OctoPlus wins Danish development, manufacturing contract

July 12, 2011
Manufacturing and Production OctoPlus, pharma manufacturing news

Dutch drug delivery specialist OctoPlus has been awarded a contract with an unidentified Danish drugmaker based on its microsphere technology. …

News

Lonza buys Arch Chemicals for $1.2 billion

July 12, 2011
Manufacturing and Production Lonza, pharma manufacturing news

Swiss fine chemical and contract manufacturing company Lonza has agreed to buy Arch Chemicals of the USA for $1.2 billion …

News

Takeda forced to withdraw Actos in France

July 11, 2011
Sales and Marketing Actos, Competact, Takeda, diabetes

Takeda has officially taken its diabetes drug Actos off the market in France at the request of the country’s medicines …

News

Cadila plant in India gets FDA warning

July 11, 2011
Manufacturing and Production Cadila, FDA warning letter, pharma manufacturing news

Indian drugmaker Cadila Healthcare has been taken to task by the US FDA for quality violations at a new sterile …

News

Chiltern Announces New Legal Entity in Israel

July 11, 2011
Research and Development

 

News
Press release

Pfizer’s ageing blockbuster Lipitor wins $770m paediatric boost

July 11, 2011
Sales and Marketing Lipitor, Pfizer, paediatric trials

Pfizer has been given more time to sell its anti-cholesterol treatment Lipitor exclusively in Europe as a quid pro quo …

News
Sanofi

Sanofi sells dermatology unit for $425m

July 11, 2011
Manufacturing and Production, Sales and Marketing Canada, Dermik, Sanofi, Valeant, dermatology

Sanofi has sold its Canadian dermatology unit Dermik for $425 million in order to concentrate on key growth areas like …

News
idea_pharma_louisa_roberts

Lousia Roberts and Ralph Torbay join Idea Pharma

July 11, 2011
Sales and Marketing appointment, sales and marketing

Idea Pharma has two new additions to its team, appointing Louisa Roberts and Ralph Torbay. Louise joins the phase II …

Appointment

Novartis’ Votubia reduces benign brain tumours in SEGA patients

July 11, 2011
Research and Development Novartis, SEGA, Votubia, everolimus

Novartis’ novel cancer drug Votubia has reduced the size of SEGA brain tumours in a late-stage trial. Votubia (or everolimus …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026